Table 3.
Antibiotic resistance profile of E. coli isolates from 2014 to 2018.
| Antibiotics | 2014 (n = 99) | 2015 (n = 85) | 2016 (n = 175) | 2017 (n = 38) | 2018 (n = 99) | Total (n = 496) |
|---|---|---|---|---|---|---|
| Ampicillin | 94% | 96.5% | 99% | 100% | 95% | 97.2% |
| Chloramphenicol | 74% | 71.4% | 83% | 80% | 78% | 78.4% |
| Ciprofloxacine | 46% | 71% | 77% | 87.5% | 76% | 71% |
| Danofloxacin | 91% | 100% | 100% | 100% | 79.5% | 84.3% |
| Doxycycline | 83% | 90% | 87.5% | 60% | 91% | 85.5% |
| Fosfomycine | 95% | 40% | 100% | 100% | 84% | 85.5% |
| Levofloxacine | 74% | 68% | 69% | 62.5% | 71% | 69.7% |
| Nalidixic acid | 87% | 100% | 91% | 88% | 93.5% | 92% |
| Norfloxacine | 83% | 68.5% | 78% | 77% | 86% | 77.3% |
| Penicillin | 83% | 100% | 100% | 100% | 100% | 95% |
| Streptomycin | 100% | 82.8% | 96.5% | 58% | 96.5% | 89.6% |
| Tetracycline | 91% | 91.4% | 99% | 93% | 89% | 93.4% |
| Trimethoprime | 91% | 87.2% | 83.5% | 84% | 88% | 86% |
| Enrofloxacine | 91% | 80% | 80% | 64% | 86% | 82.4% |
Total = total percentage of resistant strains all over five years; n = number of positive samples.